A detailed history of Jefferies Financial Group Inc. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 10,450 shares of RAPT stock, worth $18,078. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,450
Holding current value
$18,078
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.76 - $3.75 $18,392 - $39,187
10,450 New
10,450 $21,000
Q4 2023

Feb 13, 2024

SELL
$11.28 - $25.46 $400,902 - $904,873
-35,541 Reduced 72.93%
13,192 $327,000
Q1 2023

May 15, 2023

BUY
$17.19 - $30.8 $837,720 - $1.5 Million
48,733 New
48,733 $894,000

Others Institutions Holding RAPT

About RAPT Therapeutics, Inc.


  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $51.3M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.